
A UK-made vaccine to protect people against future pandemics has received global backing worth millions of pounds.
Prime Minister Boris Johnson, who opened a conference hosted by the Coalition for Epidemic Preparedness Innovations (CEPI) in London via video, hailed a new partnership between CEPI and DIOSynVax, a biotech spinout of the University of Cambridge.